Atrophy rates accelerate in amnestic mild cognitive impairment
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: We tested if rates of brain atrophy accelerate in individuals with amnestic mild cognitive impairment (aMCI) as they progress to typical late onset Alzheimer disease (AD). We included comparisons to subjects with aMCI who did not progress (labeled aMCI-S) and also to cognitively normal elderly subjects (CN).
Methods: We studied 46 subjects with aMCI who progressed to AD (labeled aMCI-P), 46 CN, and 23 aMCI-S. All subjects must have had three or more serial MRI scans. Rates of brain shrinkage and ventricular expansion were measured across all available serial MRI scans in each subject. Change in volumes relative to the point at which subjects progressed to a clinical diagnosis of AD (the index date) was modeled in aMCI-P. Change in volumes relative to age was modeled in all three clinical groups.
Results: In aMCI-P the change in pre to post index rate (i.e., acceleration) of ventricular expansion was 1.7 cm3/year, and acceleration in brain shrinkage was 5.3 cm3/year. Brain volume declined and ventricular volume increased in all three groups with age. Volume changes decelerated with increasing age in aMCI-P, and to a lesser extent in aMCI-S, but were linear in the matched CN. Among all subjects with aMCI, rates of atrophy were greater in apolipoprotein E ε4 carriers than noncarriers.
Conclusions: Rates of atrophy accelerate as individuals progress from amnestic mild cognitive impairment (aMCI) to typical late onset Alzheimer disease (AD). Rates of atrophy are greater in younger than older subjects with aMCI who progressed to AD and subjects with aMCI who did not progress. We did not find that atrophy rates varied with age in 70- to 90-year-old cognitively normal subjects.
Glossary
- AD=
- Alzheimer disease;
- aMCI=
- amnestic mild cognitive impairment;
- aMCI-P=
- subjects with aMCI who progressed to AD;
- aMCI-S=
- subjects with aMCI who did not progress;
- APOE=
- apolipoprotein E;
- AVLT=
- Auditory Verbal Learning Test;
- CDR=
- Clinical Dementia Rating;
- CN=
- cognitively normal;
- FLAIR=
- fluid attenuated inversion recovery;
- MMSE=
- Mini-Mental State Examination;
- TE=
- echo time;
- TR=
- repetition time;
- TIV=
- Total intracranial volume;
- WAIS-R=
- Wechsler Adult Intelligence Scale–Revised;
- WMS=
- Wechsler Memory Scale.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Mark Burish and Dr. Emmanuelle Schindler
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Measuring atrophy in Alzheimer diseaseA serial MRI study over 6 and 12 monthsJ. M. Schott, S. L. Price, C. Frost et al.Neurology, July 11, 2005 -
Articles
Serial MRI and CSF biomarkers in normal aging, MCI, and ADP. Vemuri, H.J. Wiste, S.D. Weigand et al.Neurology, July 12, 2010 -
Articles
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer diseaseN. C. Fox, R. S. Black, S. Gilman et al.Neurology, April 07, 2005 -
Articles
Measuring disease progression in frontotemporal lobar degenerationA clinical and MRI studyE. Gordon, J. D. Rohrer, L. G. Kim et al.Neurology, February 22, 2010